+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures



Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures



Journal of Antimicrobial ChemoTherapy 16(2): 183-188



One hundred sequential Gram-negative rod isolates from patients with hospital-acquired bloodstream infections were tested against seven new cephalosporins. Duplicate broth microdilution tests indicated superior activity for ceftazidime with 97% of strains susceptible to 16 mg/l. Less in-vitro activity was demonstrated cefotaxime (91% susceptible to 16 mg/l, P = 0.07), latamoxef (moxalactam) (90%, P = 0.04), cefoperazone (90%, P = 0.04), ceftriaxone (87%, P = 0.008), cefmenoxime (80%, P = 0.0001), and ceftizoxime (79%, P less than 0.0001). With the exception of cefoperazone, the newer drugs had mean MICs of less than or equal to 0.6 mg/l against Enterobacteriaceae. Ceftazidime and cefoperazone had highest activities against Pseudomonas aeruginosa with MIC90S of 4 and 16 mg/l, respectively. A comparison of recently published data shows important geographic differences in MIC90 data for the new cephalosporins against specific species.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 039614502

Download citation: RISBibTeXText

PMID: 3934124

DOI: 10.1093/jac/16.2.183


Related references

Rapid detection of extended-spectrum beta-lactamase-producing Gram-negative bacilli in blood cultures. Journal of Antimicrobial ChemoTherapy 60(3): 652-654, 2007

Antimicrobial interactions of Trovafloxacin combined with extended-spectrum cephalosporins tested against non-fermentative gram-negative bacilli. Abstracts of the General Meeting of the American Society for Microbiology 98: 39, 1998

Evaluation of an accelerated protocol for detection of extended-spectrum beta-lactamase-producing gram-negative bacilli from positive blood cultures. Journal of Clinical Microbiology 43(1): 439-441, 2005

Comparative studies of in vitro activity of piperacillin and 3rd generation cephalosporins against gram negative bacilli and streptococcus faecalis. Abstracts of the Annual Meeting of the American Society for Microbiology 84: ABSTRACT A33, 1984

The antibiotic susceptibility rates in the gram negative bacilli growing in urine cultures and the presence of Extended Spectrum Beta Lactamaz (ESBL). 2007

Increasing Resistance to Extended-Spectrum Cephalosporins, Fluoroquinolone, and Carbapenem in Gram-Negative Bacilli and the Emergence of Carbapenem Non-Susceptibility in Klebsiella pneumoniae: Analysis of Korean Antimicrobial Resistance Monitoring System (KARMS) Data From 2013 to 2015. Annals of Laboratory Medicine 37(3): 231-239, 2017

Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins. Pathologie-Biologie 33(5 Pt 2): 564-568, 1985

Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS284756 (T-3811) tested against non-fermentative Gram-negative Bacilli. Clinical Microbiology and Infection 8(6): 340-344, 2002

Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients. Annals of the new York Academy of Sciences 145(2): 224-236, 1967

Comparison of the activity of 6 new cephalosporins on 193 gram-negative bacilli resistant to cephalothin. Larc Medical 2(8): 637-643, 1982

New cephalosporins: in-vitro activity against gram-negative bacilli and suggestions for possible clinical use. Journal of the Oslo City Hospitals 34(5): 41-47, 1984

Comparative antimicrobial spectrum and activity of BMS284756 against three groups of non-fermentative Gram-negative bacilli, including in vitro test comparisons and development. Journal of Antimicrobial ChemoTherapy 47(Suppl. S1): 27, 2001

Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli. Antimicrobial Agents and ChemoTherapy 10(4): 657-663, 1976

Enhancing effect of serum ultrafiltrate on the activity of cephalosporins against gram-negative bacilli. Antimicrobial Agents and ChemoTherapy 33(1): 35-40, 1989

In vitro activity of 1st 2nd and 3rd generation cephalosporins against 900 clinical isolates of gram negative bacilli. Abstracts of the Annual Meeting of the American Society for Microbiology 83: A9, 1983